Legal Representation
Attorney
Andrew Abramson
USPTO Deadlines
Next Deadline
1513 days remaining
Section 8 Declaration Due (Supplemental Register) (Based on registration date 20240206)
Due Date
February 06, 2030
Grace Period Ends
August 06, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 6, 2024 | NRCS | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Feb 6, 2024 | R.SR | A | REGISTERED-SUPPLEMENTAL REGISTER | Loading... |
| Jan 2, 2024 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... |
| Dec 21, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 21, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 21, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 21, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 27, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 27, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 27, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 25, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 25, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 25, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 22, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 24, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 24, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 24, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 11, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Dietetic foods, adapted for medical purposes, in particular, for the management of Syndrome of Inappropriate Antidiuretic Hormone (SIADH) disorder and hyponatremia; pharmaceutical preparation for the management of SIADH and Hyponatremia
First Use Anywhere:
Dec 12, 2022
First Use in Commerce:
Dec 12, 2022
Classification
International Classes
005